Biohaven Balance Sheet
NYSE: BHVNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Biohaven financial position
At the end of fiscal 2025, Biohaven reported total assets of $451.4 million, down 26.6% from a year earlier against total liabilities of $399.4 million. Shareholders' equity stood at $52.1 million, or 11.5% of assets. The company held $230.0 million in cash and equivalents against $238.9 million of debt, a net debt position of $8.9 million.
The current ratio (current assets divided by current liabilities) was 3.18, meaning short-term assets cover obligations due within a year. Debt-to-equity was 4.59.
Summary generated from market data by MetaCap's automated system. Methodology
Biohaven balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 229.96M | 99.13M | 248.40M | 204.88M | 76.06M | 82.51M |
| Short-Term Investments | 89.18M | 386.86M | 133.42M | 260.46M | 0 | — |
| Total Current Assets | 368.33M | 538.47M | 442.45M | 586.97M | 94.82M | — |
| Property, Plant & Equipment | 15.96M | 17.32M | 17.19M | 17.51M | 13.01M | — |
| Goodwill | 1.39M | 1.39M | 1.39M | 1.39M | 1.39M | — |
| Intangible Assets | 18.40M | 18.40M | 18.40M | 18.40M | 18.40M | — |
| Total Assets | 451.45M | 615.11M | 513.21M | 661.78M | 142.06M | — |
| Accounts Payable | 11.64M | 18.03M | 15.58M | 10.70M | 4.78M | — |
| Total Current Liabilities | 115.93M | 154.23M | 55.42M | 90.02M | 41.94M | — |
| Long-Term Debt | 238.90M | 0 | — | — | — | — |
| Total Liabilities | 399.38M | 191.67M | 85.24M | 123.01M | 47.37M | — |
| Shareholders' Equity | 52.07M | 423.44M | 427.98M | 538.77M | 34.69M | 16.78M |
| Retained Earnings | -2.08B | -1.35B | -499.29M | -91.12M | 0 | — |
| Total Debt | 238.90M | 0 | — | — | — | — |
| Net Cash (Debt) | 80.24M | 485.99M | 381.82M | 465.34M | 76.06M | 82.51M |
| Shares Outstanding | 132.78M | 101.22M | 81.12M | 68.19M | 0 | — |
This table shows 6 annual periods of Biohaven's balance sheet, from FY 2025 back to FY 2020, across 16 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow BHVN's reporting calendar. What is a balance sheet?